Evidence map›Paper›PMID 41409718›Full record

ArticleNEJM catalyst innovations in care delivery2025

Inpatient Telehepatology at Community Hospitals: Expanding Access and Comanaging Complex Care.

Raj Vuppalanchi, Swetha Parvataneni, Loren Cihlar, Levi Longshore, Eric Orman, Archita P Desai, Naga Chalasani

Abstract read
In one paragraph

Article in NEJM catalyst innovations in care delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raj VuppalanchiProfessor of Medicine and Director of Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Swetha ParvataneniAssistant Professor of Medicine Practice and Hepatology Research Fellow, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Loren CihlarPhysician Assistant, Gastroenterology - Hepatology, Indiana University Health, Indianapolis, Indiana, USA.
Levi LongshoreData Coordinator, Indiana University Health, Indianapolis, Indiana, USA.
Eric OrmanAssociate Professor of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Archita P DesaiAssistant Professor of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Naga ChalasaniDavid W. Crabb Professor of Medicine and Vice President for Academic Affairs, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.

Funding

The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in CirrhosisK23DK123408 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DESAI, ARCHITA P. · 2020 to 2024
$903k
Innovating acute care for liver disease through a pilot, patient-centric Hospital@Home programR03DK139283 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DESAI, ARCHITA P. · 2024 to 2025
$248k
NIDDK NIH HHS K23 DK123408NIDDK NIH HHS R03 DK139283
6 · The paper itself

Abstract

The complexity of care for decompensated liver disease often necessitates the transfer of patients to tertiary care hospitals (TCHs) for management by advanced liver care teams. However, TCHs often have a wait list for transfers, which can lead to delays in timely care. These delays can increase the risk of medical errors, which can be compounded by the multiple handoffs and uncertainty during the transfer process. To address these limitations and reduce reliance on transfers, the Indiana University Health Hepatology team, based at the academic health center (AHC), implemented a remote inpatient telehepatology (INP-TH) consultation service for comanaging patients with advanced liver disease while they remain hospitalized at one of the integrated health care system's community hospitals. In this article, the authors describe the logistics, feasibility, and selected outcomes of the INP-TH service across three of the community hospitals. Multiple stakeholders at the community hospitals and from the health system leadership were engaged before establishing the service. The service was implemented at minimal additional cost, utilizing existing clinical staff and two patient-facing iPads at each community hospital. AHC-based dedicated inpatient hepatology physician assistants and hepatology attendings participated in the INP-TH consultations. Patients under evaluation in the ED or those receiving care in the ICU were not eligible for the INP-TH consultation request. The results presented are from the virtual consultations offered to 155 patients from July 1, 2022, to December 31, 2023. On establishing INP-TH, only 12 patients (8%) were transferred to the AHC at the discretion of the INP-TH team for reasons related to the severity of illness or specialized services only available at the AHC; the other 143 (92%) were comanaged locally. Of the 155 patients, 57% had an outpatient hepatology follow-up within 30 days, 28% were readmitted to a hospital within 30 days, and 8% died within 30 days, which included nine as inpatients and four as outpatients. Provider engagement and satisfaction surveys revealed strong support and high satisfaction levels from both hepatology providers and hospitalists, with no readily evident risk to the patients. The INP-TH initiative models an approach for locally comanaging patients with complex or advanced diseases by establishing the feasibility and efficacy of comanagement of patients with decompensated cirrhosis at community hospitals without the need for physical transfer. To enhance its scale and breadth, the adaptation and expansion of the service to other health care systems should be explored.

Identifiers

PMID41409718
PMCPMC12707029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.